Stockholders' Deficit (Details Textual) - USD ($)			1 Months Ended			12 Months Ended
	Jun. 30, 2018	Jun. 29, 2018	Jul. 29, 2019	Jul. 23, 2019	Jun. 22, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2016
Preferred stock, par value						$ 0.00001	$ 0.00001
Preferred stock, authorized						15,000,000	15,000,000
Designated shares						4,471,489
Series Seed I preferred outstanding
Shares per shares						$ 2.63
Common stock authorized						50,000,000	50,000,000
Common stock par value						$ 0.00001	$ 0.00001
Shares based compensation						$ 1,988,626	$ 2,280,842
Legal services value						$ 610,550
Shares of restricted common stock						360,000	264,285
Description of collateralized restricted stock purchases								The Company issued 1,032,387 shares of restricted common stock to related parties that vest as follows: 33% upon a sale of securities for gross proceeds of at least $250,000 in one or more transactions and the remaining 67% vest monthly over three years, becoming fully vested in April 2019. For consideration of these shares, the related parties entered into note agreements totaling $138,700 that call for the principal and interest to be paid back in ten years from the date of the loan. The notes bear interest at 1%. The loans are secured by the related shares of common stock. On May 31, 2018, the board of directors determined that it was in the best interest of the Company, in order to comply with the requirements of Section 402 of the Sarbanes-Oxley Act of 2002 prior to filing the IPO registration statement with the SEC, to (i) issue a bonus to those related parties serving as an officer and/or director of the Company in the amount owed by each party. Each such related party bonus was used to repay and terminate the note agreements. An aggregate of $131,400 in principal was repaid and terminated along with accrued interest thereon. Remaining balance of $7,447 is outstanding to a related party that is not serving as an officer or director of the Company. As of December 31, 2019, all shares were vested.
Granted options exercise prices ranging						$ 6.25
Fair value of options granted						$ 607,550
Stock options forfeited						400,000
Stock option expense						$ 1,047,686	$ 446,417
Shares and services, description						Each share of Series Seed 1 shall be convertible, at the option of the holder and at any time, into such number of shares of common stock as determined by dividing the Series Seed 1 original issue price by $0.71, subject to customary adjustments for stock dividends, stock splits, or other recapitalization with respect to the Series Seed 1.
Stock-based compensation expense weighted average period term						2 years 3 months 19 days
Stock-based compensation							$ 1,321,425
Stock-based compensation expenses, description						Stock-based compensation related to restricted stock units and forfeitable restricted common stock issued for services for the year ended December 31, 2019 and 2018 was $330,390 and $1,371,425, respectively. As of December 31, 2019, unrecognized compensation expense related to the unvested restricted stock units is $933,684 and is expected to be recognized over approximately 2.4 years.	The Company also granted 10,000 shares of restricted common stock to a consultant for services which fully vested upon the IPO. The Company recognized stock-based compensation expense of $50,000 during the year ended December 31, 2018 for the vesting of the 10,000 shares of restricted common stock. In addition, the Company also agreed to issue the consultant an aggregate of 825,000 shares of restricted common stock with the issuance of 275,000 shares of restricted common stock upon each of three milestones. These milestones were not met and as of December 31, 2018, these equity awards were forfeited due to termination of service with the Company.
Warrants to purchase of common stock shares						75,600
Unvested restricted stock expense						$ 330,390
Stock option, description								The board of directors approved the grant of 1,125,000 and 697,500 stock options to various contractors and employees, respectively. The 2019 granted options had an exercise prices ranging from $3.20 - $5.53, expire in ten years, and had vesting periods from two to four years. The 2018 granted options had an exercise prices ranging from $2.21 - $5.00, expire in ten years, and had vesting periods from two to four years. The total grant date fair value of options granted to employees was approximately $2,077,801 and $1,120,995 for the years ended December 31, 2019 and 2018, respectively.
Acquisition of stock, description							The 2018 Plan provides for the grant of equity awards to purchase shares of common stock. Up to 3,000,000 shares of common stock may be issued pursuant to awards granted under the 2018 Plan, subject to increases that occur starting in 2021. The 2018 Plan is administered by the Board of Directors, and expires ten years after adoption, unless terminated earlier by the Board.	The 2016 Plan provides for the grant of equity awards to highly qualified personnel, including stock options, restricted stock, stock appreciation rights, and restricted stock units to purchase shares of common stock. Up to 2,227,777 shares of common stock may be issued pursuant to awards granted under the 2016 Plan.
Series Seed 1 shares issued						2,429,638
Public offering price, percentage							125.00%
Granted restricted stock units vest						360,000
Granted restricted stock						400,000
Granted restricted stock units were forfeited						400,000
Granted common shares						135,000
Warrants exercised for cash						$ 873,403
Convertible Debt [Member]
Stock issued services							15,455
Warrants to purchase common stock							615,585
Warrant exercise price							$ 3.185
Initial Public Offering [Member]
Sale of common stock per shares			$ 3.00	$ 3.00
Common shares sold			4,025,000	4,025,000
Common stock issued and sold		2,520,000
Common stock, per share		$ 5.00
Underwriters gross proceeds		$ 12,600,000
Underwriters’ discounts and commissions		1,260,000	$ 603,750	$ 603,750
Underwriters net proceeds		11,340,000
Underwriters deducting offering costs		$ 569,665
Unvested stock options [Member]
Stock-based compensation expenses, description						The total estimated remaining stock-based compensation expense for unvested stock options is approximately $1,758,562 which is expected to be recognized over a weighted average period of 2.3 years.
Stock Options [Member]
Number of shares, Granted						1,125,000	697,500
Stock-based compensation [Member]
Stock-based compensation	$ 463,000
Warrant exercise price	$ 5.00
Cash compensation and warrants	250,000
Stock-based compensation [Member] | Minimum [Member]
Warrants term	3 years
Stock-based compensation [Member] | Maximum [Member]
Warrants term	5 years
Warrant One [Member]
Warrants to purchase common stock					28,993
Warrant remaining shares					63,267
Warrant exercise price					$ 7.50
Warrant [Member]
Warrants to purchase common stock					60,392
Warrants to acquire common stock					123,659
Number of shares, Granted							1,046,025
Warrant exercise price					$ 2.00
Warrants exercised - cashless, shares						174,502
Warrants exercised for cash, shares						274,224